Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $251.67 ($3.8M) on 2013-06-10, disclosed to the SEC on 2013-06-12.
Scheduled sale ($3.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $250.06 | 4,150 | $1.0M | 27.5% |
| 2 | $251.67 | 3,938 | $991K | 26.2% |
| 3 | $252.32 | 4,748 | $1.2M | 31.7% |
| 4 | $253.50 | 908 | $230K | 6.1% |
| 5 | $254.10 | 756 | $192K | 5.1% |
| 6 | $255.16 | 200 |
| $51K |
| 1.4% |
| 7 | $257.99 | 300 | $77K | 2.0% |
| Total | $251.84 avg | 15,000 | $3.8M | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |